- AU$757.22m
- AU$681.01m
- AU$0.03m
Australia's Artrya at three-week peak on deal with US co
Brief: Artrya To Raise About A$75 Mln Via Placement At Issue Price Of A$2.05 Per Share
Brief: Artrya Raises A$75 Million In Placement At A$2.05 Per Share
Brief: Artrya Ltd Requests Trading Halt
Brief: Artrya Announces FDA Clearance Of Salix Coronary Plaque Module
Brief: Artrya Ltd Posts FY Loss Attributable A$16.4 Million
Australia's Artrya rises to highest since January on US hospital group contract
Brief: Artrya Says John Konstantopoulos Appointed As CEO
Brief: Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module
Brief: Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary Anatomy
Australia's Artrya climbs as FDA clears Salix for US sale
Brief: Artrya Secures FDA Clearance For Salix Coronary Anatomy
Brief: Artrya Reports HY Loss From Ordinary Activities After Tax Attributable A$7.4 Mln
Australia's Artrya slips most in over 2 weeks on discounted placement
Brief: Artrya Announces A$15 Million Placement
Brief: Artrya Secures Multi-Year Contract With Sonic Healthcare
Brief: Artrya Ltd Seeks Trading Halt
Australia's Artrya falls on discounted placement
Brief: Artrya Announces A$5 Mln Placement At A$0.42 Per Share